Biocon surges 14% after US FDA gives approval to biosimilar version of Herceptin

Mylan and Biocon said that USFDA approved Mylan’s Ogivri, a biosimilar to Swiss biotech giant Roche#39;s blockbuster cancer drug Herceptin, co-devel...